Last update 01 Nov 2024

IL-12R x CTLA4 x FLT3

Basic Info

Related Targets
IL-12RCTLA4FLT3

Related

1
Drugs associated with IL-12R x CTLA4 x FLT3
RIVAL-01
Target
CTLA4 x FLT3 x IL-12R
Mechanism
CTLA4 inhibitors [+4]
Active Org.-
Originator Org.
Turnstone Biologics, Inc.Turnstone Biologics, Inc.
Active Indication-
Inactive Indication
Advanced Malignant Solid Neoplasm [+9]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with IL-12R x CTLA4 x FLT3
NCT04301011 / TerminatedPhase 1/2
A Phase 1/2a, Multicenter, Open-label Trial of TBio-6517, an Oncolytic Vaccinia Virus, Administered Alone and in Combination With Pembrolizumab, in Patients With Advanced Solid Tumors
100 Clinical Results associated with IL-12R x CTLA4 x FLT3
Login to view more data
100 Translational Medicine associated with IL-12R x CTLA4 x FLT3
Login to view more data
0 Patents (Medical) associated with IL-12R x CTLA4 x FLT3
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free